Articles

Prostate cancer patients who also have long-term diabetes mellitus and/or diabetes with organ failure may have a higher likelihood of developing more aggressive, poorly differentiated disease….

The evidence for a link between the body clock hormone melatonin and type 2 diabetes continues to mount….

Stroke and subclinical markers of vascular disease may help predict which older patients with type 2 diabetes will develop cognitive decline….

In patients with type 2 diabetes, insulin sensitivity and beta-cell function improved similarly with a very-low-calorie diet compared to bariatric surgery….

Two more common conditions in pregnancy double the odds of being diagnosed with diabetes years later….

The find is crucial for fat research and future treatment of obesity….

There is currently fierce competition to get SGLT2 medications approved and onto the market. The first SGLT2 drug, Invokana (canagliflozin), developed by Johnson and Johnson, was approved by the FDA just recently. Ertugliflozin, which is ready for Phase III trials, will likely be marketed as a drug taken on its …

A screening program for diabetic retinopathy diminished the likelihood of eye disease in patients with diabetes….

Teens targeting strength, cardio fitness battle insulin resistance….

A two-step process consisting of one drug to induce immune tolerance and another to promote islet regeneration could be key to type 1 diabetes reversal….